Some people who abuse drugs show symptoms similar to those of schizophrenia, and people with schizophrenia may be mistaken for people who are high on drugs. While most researchers do not believe that substance abuse causes schizophrenia, people who have schizophrenia abuse alcohol and/or drugs more often than the general population.
As you may have gathered by now, I am no longer employed with Kaiser and if I had not resigned my position, would probably have been fired for my thorough review of the records I reviewed. I did not hesitate to speak loudly and frequently about the discrepancies I had found — and, as such, was not viewed as a valuable asset! (In fact, I had been “disciplined” and given poor performance evaluations for essentially doing the job that was required of me — audit for the complete and accurate documentation in the medical record).
2011: In January, the Neurological Devices Panel meeting was held. After reviewing studies, practice guidelines, adverse events reported to the FDA, public docket submissions, the FDA’s review of published studies and more, the panel recommended staying at a Class III for schizophrenia, bipolar mania (and mixed states), schizoaffective disorder and schizophreniform disorder. The panel did not reach a consensus on classification of ECT for catatonia or depression.  When discussing ECT for the use of depression, however, nine panel members supported a Class III designation while only eight panel members thought it should be reclassified to Class II.  Dr. Matthew Rudorfer, a psychiatrist who administers and oversees grant money for the National Institute of Mental Health (NIMH), including for electroshock research, told The New York Times in January that new clinical trials “might be too expensive” for the manufacturers to prove their device was safe and effective as the companies “tend to be mom-and-pop operations.